INKT Archived Articles
MiNK Therapeutics (NASDAQ:INKT): Pioneering Allogeneic iNKT Cell Therapies to Transform Cancer and Immune-Mediated Diseases
Published on March 11, 2025
MiNK Therapeutics (NASDAQ:INKT): Pioneering Allogeneic iNKT Cell Therapies to Transform Cancer and Immune-Mediated Diseases
Published on November 30, 2024
MiNK Therapeutics, Inc. (INKT): A Promising Biotech Poised for Transformative Growth
Published on September 24, 2024